Organization
Sichuan Cancer Hospital and Research Institute
12 clinical trials
Clinical trial
A Prospective Randomized Controlled Trials of Neoadjuvant Chemotherapy Combined With Serplulimab Followed by Concurrent Chemoradiation Versus Concurrent Chemoradiation Therapy Alone in Advanced Cervical CancerStatus: Recruiting, Estimated PCD: 2027-12-28
Clinical trial
A Single-arm, Open-label, Multi-cohort, Multi-center Phase II Clinical Study of Anlotinib Combined With Penpulimab in the Treatment of Recurrent or Metastatic Gynecological CancerStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Retrospective Study of the Efficacy and Safety of Lolatinib in Anaplastic Lymphoma Kinase (ALK) - Positive Non-Small Cell Lung Cancer (NSCLC) Patients With Brain or Meningeal MetastasisStatus: Active (not recruiting), Estimated PCD: 2024-03-31
Clinical trial
PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II TrialStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Clinical trial
Real World Study of Lolatinib for Patients With Advanced/Metastatic Anaplastic Lymphoma Kinase (ALK) - Positive Non-Small Cell Lung Cancer (NSCLC)Status: Recruiting, Estimated PCD: 2026-11-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled Clinical Study on Prevention and Treatment of CINV Induced by TC Regimen in Gynecological Malignant TumorsStatus: Not yet recruiting, Estimated PCD: 2025-02-10
Clinical trial
Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell CarcinomaStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Clinical trial
Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal CarcinomaStatus: Completed, Estimated PCD: 2020-04-01
Clinical trial
Radiotherapy Combined With Nitozumab and Sinilimab in the Treatment of Locally Advanced Unresectable Platinum Intolerant Head and Neck Squamous Cell Carcinoma： an Open-label Single-arm, Phase II TrialStatus: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
Effect of Intravenous Lidocaine Infusion on Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy: a Multicenter, Double-blind, Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2024-08-30
Clinical trial
Drug-eluting Beads Transarterial Chemoembolization Combined With Apatinib and PD-1 Antibody for the Treatment of Intrahepatic Cholangiocarcinoma That Has Progressed After Standard First-line ChemotherapyStatus: Recruiting, Estimated PCD: 2025-04-30
Clinical trial
TACE Combined With Sorafenib and PD-1 mAb in the Treatment of BCLC B/C Hepatocellular Carcinoma: Single Arm, Single Center, Open Label StudyStatus: Completed, Estimated PCD: 2022-07-31